While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

A new technology that uses clinical MRI machines to image metabolic activity in the brain could give researchers and ...

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Multiple sclerosis (MS) is a demyelinating disease that affects the central nervous system (CNS) and is characterized by the presence of CNS lesions. Volumetric measures of tissues, including lesions, ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

Using population-based data from the UK Biobank from multiple imaging sites, investigators tested whether clinical and neurobiological heterogeneity have a simple relationship (“one-to-one ...

In 2024, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress celebrated a remarkable 40 years of pioneering work. Regional committees have emerged around the ...

In multiple sclerosis (MS), diffuse degenerative processes in the deep grey matter have been associated with clinical disabilities. We performed a systematic study in MS deep grey matter with a focus ...

Brain Atrophy in MS Brain volume measurements are not used in routine clinical practice, but it is a very attractive MRI metric in MS because it is clinically relevant, robust and could offer an ...

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control ...